
European Journal of Medicinal Chemistry p. 217 - 226 (1990)
Update date:2022-08-04
Topics:
Brown
Armitage
Blakemore
Blurton
Durant
Ganellin
Ife
Parsons
Rawlings
Slingsby
A series of 2-[2-(5-dimethylaminomethyl-2-furanylmethylthio)ethylamino]-4-pyrimidones is described containing a variety of substituents in the 5-position of the pyrimidone (isocytosine) ring. Good H2-receptor histamine antagonist activity is retained over a range of basic and neutral, polar and non-polar substituents and the majority of compounds are selective for the H2-receptor. Modifications have also been made to the furan ring and N,N-dimethylaminomethyl substituent and structure-activity observations are discussed. Compound (16f) 2-[2-(5-dimethylaminomethyl-2-furanylmethylthio)ethylamino]-5-(6-methyl-3- pyridylmethyl)-4-pyrimidone (SK and F 93479, lupitidine), a compound which shows an extended duration of anti-secretory activity in animal models, was selected for clinical investigation.
View MoreMedicalChem(Yancheng)Manuf.Co.,Ltd.
Contact:+86-515-84383366
Address:Touzeng BinHai, YanCheng City, JiangSu Province, China
Tianjin Te-An Chemtech Co., Ltd.(expird)
Contact:+86-22-65378638
Address:A5-8, No.80 Haiyun Street, TEDA
Contact:+86-511-88790000
Address:338 North Yushan Rd, Zhenjiang, Jiangsu 212016
Contact:+91 9963263336
Address:Plot#146A, IDA Mallapur, Hyderabad - 500072
Contact:+86-15850770348
Address:51 OF XIANGFANGCUN ROAD, Nanjing 210002, China
Doi:10.1246/bcsj.39.1201
(1966)Doi:10.1002/hlca.19800630125
(1980)Doi:10.1080/00397919308013297
(1993)Doi:10.1021/jo00379a018
(1987)Doi:10.1007/BF02665113
(1956)Doi:10.1039/P19910000781
(1991)